|
US7205307B2
(en)
*
|
2002-02-14 |
2007-04-17 |
Icagen, Inc. |
Pyrimidines as novel openers of potassium ion channels
|
|
EP1601666A2
(de)
*
|
2002-07-02 |
2005-12-07 |
Schering Corporation |
Neuropeptid y y5 rezeptor antagonisten
|
|
US7186735B2
(en)
*
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
EP1388535A1
(de)
*
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylierte Arylcycloalkylamine und ihre Anwendung als Arzneimittelwirkstoff
|
|
GB0219961D0
(en)
*
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
|
AU2003295041A1
(en)
*
|
2002-11-20 |
2004-06-18 |
L'oreal |
Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof
|
|
RU2332412C2
(ru)
|
2003-02-07 |
2008-08-27 |
Дайити Фармасьютикал Ко., Лтд. |
Производные пиразола
|
|
US7531558B2
(en)
*
|
2003-02-14 |
2009-05-12 |
Glaxo Group Limited |
Carboxamide derivatives
|
|
SE0300705D0
(sv)
*
|
2003-03-14 |
2003-03-14 |
Biolipox Ab |
New compounds
|
|
DE602004027171D1
(de)
*
|
2003-04-11 |
2010-06-24 |
High Point Pharmaceuticals Llc |
Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
|
|
AR045979A1
(es)
*
|
2003-04-28 |
2005-11-23 |
Astrazeneca Ab |
Amidas heterociclicas
|
|
EP1617840A4
(de)
|
2003-05-01 |
2008-08-20 |
Bristol Myers Squibb Co |
Pyrazole-amid-verbindungen als kinase-hemmer
|
|
US20040220170A1
(en)
*
|
2003-05-01 |
2004-11-04 |
Atkinson Robert N. |
Pyrazole-amides and sulfonamides as sodium channel modulators
|
|
US20050004133A1
(en)
*
|
2003-06-05 |
2005-01-06 |
Makings Lewis R. |
Modulators of VR1 receptor
|
|
US20060281803A1
(en)
*
|
2003-09-23 |
2006-12-14 |
Lindsley Craig W |
Pyrazole modulators of metabotropic glutamate receptors
|
|
DE10360369A1
(de)
*
|
2003-12-22 |
2005-07-14 |
Bayer Cropscience Ag |
Amide
|
|
AU2005214375A1
(en)
*
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Triazole compounds and their use as metabotropic glutamate receptor antagonists
|
|
CA2560510C
(en)
|
2004-03-18 |
2009-10-13 |
Pfizer Inc. |
N-(1-arylpyrazol-4yl) sulfonamides and their use as parasiticides
|
|
WO2006028958A2
(en)
|
2004-09-02 |
2006-03-16 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
WO2006032851A1
(en)
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
|
WO2006032852A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful uin the treatment of inflammation
|
|
MX2007004403A
(es)
|
2004-10-12 |
2007-04-27 |
Astrazeneca Ab |
Derivados de quinazolina.
|
|
US7728009B1
(en)
|
2005-02-18 |
2010-06-01 |
Neurogen Corporation |
Thiazole amides, imidazole amides and related analogues
|
|
AR053710A1
(es)
|
2005-04-11 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
|
|
MY144968A
(en)
|
2005-04-11 |
2011-11-30 |
Xenon Pharmaceuticals Inc |
Spiro-oxindole compounds and their uses as therapeutic agents
|
|
JPWO2006132192A1
(ja)
*
|
2005-06-07 |
2009-01-08 |
大日本住友製薬株式会社 |
新規2−キノロン誘導体
|
|
CN1884262B
(zh)
*
|
2005-06-24 |
2014-06-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-氨基哌啶类化合物及其医药用途
|
|
WO2007021941A2
(en)
*
|
2005-08-16 |
2007-02-22 |
Icagen, Inc. |
Inhibitors of voltage-gated sodium channels
|
|
EP1772449A1
(de)
*
|
2005-10-05 |
2007-04-11 |
Bayer CropScience S.A. |
N-alkyl-heterocyclische carboxamide Derivate
|
|
WO2007073432A2
(en)
*
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
TW200800911A
(en)
*
|
2005-10-20 |
2008-01-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
|
AU2006310367A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Biolipox Ab |
Triazole compounds as lipoxygenase inhibitors
|
|
TW200732320A
(en)
*
|
2005-10-31 |
2007-09-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
|
US20090088463A1
(en)
*
|
2005-11-01 |
2009-04-02 |
Benjamin Pelcman |
Pyrazoles Useful in the Treatment of Inflammation
|
|
EP1787981A1
(de)
*
|
2005-11-22 |
2007-05-23 |
Bayer CropScience S.A. |
Neue N-phenethylcarboxamidderivate
|
|
EP1991528A2
(de)
*
|
2006-01-18 |
2008-11-19 |
Siena Biotech S.p.A. |
Modulatoren von alpha7-nicotinischen acetylcholinrezeptoren und therapeutische verwendungen davon
|
|
FR2897061B1
(fr)
*
|
2006-02-03 |
2010-09-03 |
Sanofi Aventis |
Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.
|
|
UY30183A1
(es)
|
2006-03-02 |
2007-10-31 |
Astrazeneca Ab |
Derivados de quinolina
|
|
CN101405270B
(zh)
|
2006-03-22 |
2013-01-16 |
霍夫曼-拉罗奇有限公司 |
作为11-β-HSD-1的吡唑类
|
|
MX2008013194A
(es)
|
2006-04-11 |
2008-12-01 |
Vertex Pharma |
Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
|
|
US20110207771A1
(en)
*
|
2006-06-08 |
2011-08-25 |
Syngenta Crop Protection, Inc. |
N-(l-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
|
|
PE20080401A1
(es)
|
2006-07-07 |
2008-06-23 |
Boehringer Ingelheim Int |
DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
|
|
WO2008014199A2
(en)
|
2006-07-28 |
2008-01-31 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 receptor
|
|
JPWO2008023720A1
(ja)
*
|
2006-08-23 |
2010-01-14 |
アステラス製薬株式会社 |
ウレア化合物又はその塩
|
|
KR20090069318A
(ko)
|
2006-09-25 |
2009-06-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
Cb2 수용체를 조절하는 화합물
|
|
WO2008045484A1
(en)
*
|
2006-10-10 |
2008-04-17 |
Amgen Inc. |
N-aryl pyrazole compounds for use against diabetes
|
|
WO2008046084A2
(en)
*
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
|
EP2073806B1
(de)
|
2006-10-12 |
2012-02-15 |
Xenon Pharmaceuticals Inc. |
Verwendung von spiro-oxindol-verbindungen als therapeutika
|
|
US8173638B2
(en)
*
|
2006-11-21 |
2012-05-08 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
JP2010043004A
(ja)
*
|
2006-12-06 |
2010-02-25 |
Dainippon Sumitomo Pharma Co Ltd |
新規2環性複素環化合物
|
|
CL2008000512A1
(es)
|
2007-02-22 |
2008-08-29 |
Bayer Cropscience Sa |
Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
|
|
EA015952B1
(ru)
*
|
2007-05-03 |
2011-12-30 |
Пфайзер Лимитед |
2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
|
|
CL2008001647A1
(es)
|
2007-06-08 |
2008-10-10 |
Syngenta Participations Ag |
Compuestos derivados de feniletil-amida de acido-1h-pirazol-4-carboxilico; compuestos derivados de (feniletil)amina; metodo para controlar o prevenir la infestacion de plantas por parte de microorganismos fitopatogenos; y composicion para el control
|
|
CL2008001943A1
(es)
|
2007-07-02 |
2009-09-11 |
Boehringer Ingelheim Int |
Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes.
|
|
US8853250B2
(en)
|
2007-07-13 |
2014-10-07 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
CN101711245B
(zh)
*
|
2007-07-19 |
2015-03-25 |
H.隆德贝克有限公司 |
5元杂环酰胺及相关的化合物
|
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
|
MX2010003864A
(es)
|
2007-10-11 |
2010-06-01 |
Vertex Pharma |
Amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
|
|
CA2701946A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
|
EP2212290B1
(de)
|
2007-10-11 |
2014-12-03 |
Vertex Pharmaceuticals Incorporated |
Als inhibitoren von spannungsabhängigen natriumkanälen geeignete arylamide
|
|
EP2217565B1
(de)
|
2007-11-07 |
2013-05-22 |
Boehringer Ingelheim International GmbH |
Cb2 rezeptor-modulierende verbindungen
|
|
JPWO2009101917A1
(ja)
|
2008-02-13 |
2011-06-09 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ビシクロアミン誘導体
|
|
DE102008015033A1
(de)
|
2008-03-17 |
2009-09-24 |
Aicuris Gmbh & Co. Kg |
Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
|
|
DE102008015032A1
(de)
|
2008-03-17 |
2009-09-24 |
Aicuris Gmbh & Co. Kg |
Substituierte Pyrazolamide und ihre Verwendung
|
|
US20210130285A1
(en)
|
2008-03-19 |
2021-05-06 |
Aurimmed Pharma, Inc. |
Novel compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
US9212155B2
(en)
|
2008-03-19 |
2015-12-15 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
JP5746612B2
(ja)
|
2008-03-19 |
2015-07-08 |
オーリムメッド・ファルマ・インコーポレーテッド |
中枢神経系疾患および障害の治療に有効な新規化合物
|
|
US20090281089A1
(en)
*
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
JP5216912B2
(ja)
|
2008-04-29 |
2013-06-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr1受容体拮抗薬としてのインダゾール化合物
|
|
JP5411927B2
(ja)
*
|
2008-05-06 |
2014-02-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr1アンタゴニストとしてのピラゾール化合物
|
|
SG188117A1
(en)
|
2008-06-19 |
2013-03-28 |
Takeda Pharmaceutical |
Heterocyclic compound and use thereof
|
|
EP2326629B1
(de)
|
2008-07-10 |
2013-10-02 |
Boehringer Ingelheim International GmbH |
Den cb2-rezeptor modulierende sulfonverbindungen
|
|
CA2737645A1
(en)
*
|
2008-09-25 |
2010-04-01 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the cb2 receptor
|
|
PE20110854A1
(es)
|
2008-09-26 |
2011-12-23 |
Boehringer Ingelheim Int |
DERIVADOS DE 1-FENIL-1H-PIRAZOLO[3,4-c]PIRIDINA-4-CARBONILAMINA COMO ANTAGONISTAS DE LOS RECEPTORES CCR1
|
|
EP2350052B1
(de)
|
2008-09-29 |
2014-08-13 |
Boehringer Ingelheim International GmbH |
Antiproliferative verbindungen
|
|
HRP20150882T1
(hr)
|
2008-10-17 |
2015-09-25 |
Xenon Pharmaceuticals Inc. |
Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva
|
|
WO2010045197A1
(en)
|
2008-10-17 |
2010-04-22 |
Xenon Pharmaceuticals, Inc. |
Spiro-oxindole compounds and their use as therapeutic agents
|
|
DE102008062878A1
(de)
|
2008-12-17 |
2010-06-24 |
Aicuris Gmbh & Co. Kg |
Substituierte Furancarboxamide und ihre Verwendung
|
|
DE102008062863A1
(de)
|
2008-12-17 |
2010-06-24 |
Aicuris Gmbh & Co. Kg |
Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
|
|
EP2379524A1
(de)
|
2008-12-18 |
2011-10-26 |
Boehringer Ingelheim International GmbH |
Inhibitoren des serotonin-5-ht2b-rezeptors
|
|
US20110269788A1
(en)
|
2008-12-29 |
2011-11-03 |
Xenon Pharmaceuticals Inc. |
Spiro-oxindole-derivatives as sodium channel blockers
|
|
KR101605061B1
(ko)
|
2009-05-29 |
2016-03-21 |
라퀄리아 파마 인코포레이티드 |
칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체
|
|
US8299103B2
(en)
|
2009-06-15 |
2012-10-30 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
|
WO2010147791A1
(en)
|
2009-06-16 |
2010-12-23 |
Boehringer Ingelheim International Gmbh |
Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
DE102009036604A1
(de)
|
2009-07-30 |
2011-02-03 |
Aicuris Gmbh & Co. Kg |
Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
|
|
EP2480544A1
(de)
|
2009-09-22 |
2012-08-01 |
Boehringer Ingelheim International GmbH |
Verbindungen für selektive cb2-rezeptormodulation
|
|
PE20170202A1
(es)
|
2009-10-14 |
2017-03-24 |
Xenon Pharmaceuticals Inc |
Metodos sinteticos para compuestos espiro-oxoindol
|
|
AP2012006204A0
(en)
|
2009-10-21 |
2012-04-30 |
Boehringer Ingelheim Int |
Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists.
|
|
JP5542214B2
(ja)
|
2009-10-27 |
2014-07-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr1受容体アンタゴニストとしての複素環化合物
|
|
IN2012DN05081A
(de)
*
|
2009-12-08 |
2015-10-09 |
Boehringer Ingelheim Int |
|
|
EP2523936A1
(de)
|
2010-01-15 |
2012-11-21 |
Boehringer Ingelheim International GmbH |
Cb2 rezeptor-modulierende verbindungen
|
|
RU2596488C2
(ru)
|
2010-02-26 |
2016-09-10 |
Ксенон Фармасьютикалз Инк. |
Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов
|
|
US8329735B2
(en)
|
2010-03-05 |
2012-12-11 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the CB2 receptor
|
|
US9290507B2
(en)
|
2010-03-26 |
2016-03-22 |
Boehringer Ingelheim International Gmbh |
B-RAF kinase inhibitors
|
|
EP2552907B1
(de)
|
2010-03-26 |
2014-10-22 |
Boehringer Ingelheim International GmbH |
Pyridyltriazole
|
|
US8871786B2
(en)
|
2010-04-30 |
2014-10-28 |
Boehringer Ingelheim International Gmbh |
Azaindazole amide compounds as CCR1 receptor antagonists
|
|
WO2012012307A1
(en)
|
2010-07-22 |
2012-01-26 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 rece
|
|
EP2630122B1
(de)
*
|
2010-10-18 |
2016-11-30 |
RaQualia Pharma Inc |
Arylamidderivate als ttx-s-blocker
|
|
JP5795643B2
(ja)
*
|
2010-10-21 |
2015-10-14 |
グラクソ グループ リミテッドGlaxo Group Limited |
アレルギー性状態、免疫性状態及び炎症性状態に作用するピラゾール化合物
|
|
WO2012052459A1
(en)
*
|
2010-10-21 |
2012-04-26 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
WO2012061926A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Zalicus Pharmaceuticals Ltd. |
Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
|
|
AR083987A1
(es)
|
2010-12-01 |
2013-04-10 |
Bayer Cropscience Ag |
Amidas de acido pirazolcarboxilico utiles para la reduccion de la contaminacion de micotoxina en las plantas
|
|
US8710055B2
(en)
|
2010-12-21 |
2014-04-29 |
Boehringer Ingelheim International Gmbh |
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
|
US8546442B2
(en)
|
2010-12-23 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Pyrazolopiperidine compounds as CCR1 receptor antagonists
|
|
NZ618795A
(en)
|
2011-05-13 |
2015-07-31 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
WO2012177263A1
(en)
*
|
2011-06-24 |
2012-12-27 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists
|
|
DE102011055815A1
(de)
|
2011-11-29 |
2013-05-29 |
Aicuris Gmbh & Co. Kg |
Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
|
|
CN104302640A
(zh)
|
2012-03-16 |
2015-01-21 |
埃克希金医药品有限公司 |
3,5-二氨基吡唑激酶抑制剂
|
|
EA027855B1
(ru)
*
|
2012-04-17 |
2017-09-29 |
Гайлид Сайэнсиз, Инк. |
Соединения и способы для противовирусной терапии
|
|
IN2014MN01982A
(de)
*
|
2012-04-25 |
2015-07-10 |
Raqualia Pharma Inc |
|
|
DE102012016908A1
(de)
|
2012-08-17 |
2014-02-20 |
Aicuris Gmbh & Co. Kg |
Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
|
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
|
CN103772284B
(zh)
*
|
2012-10-23 |
2015-08-12 |
沈阳感光化工研究院 |
一种4,5-二氨基-1-(2-羟乙基)吡唑硫酸盐的制备方法
|
|
CN102993097A
(zh)
*
|
2012-11-09 |
2013-03-27 |
贵州大学 |
吡唑酰胺类化合物及其应用
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
ME02990B
(de)
|
2012-11-13 |
2018-10-20 |
Array Biopharma Inc |
N-pyrrolidinyl-, n'-pyrazolyl-harnstoff-, thioharnstoff-, guanidin- und cyanoguanidinverbindungen als trka-kinaseinhibitoren
|
|
CA2891334C
(en)
|
2012-11-13 |
2021-10-19 |
Array Biopharma Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
MX2015008919A
(es)
|
2013-01-10 |
2015-10-22 |
Gruenenthal Gmbh |
Carboxamidas basadas en pirazolilo i como inhibidores del canal de calcio activado por liberacion de calcio (crac).
|
|
JP2016504397A
(ja)
|
2013-01-10 |
2016-02-12 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Cracチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類ii
|
|
EP2803668A1
(de)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole
|
|
TWI636047B
(zh)
|
2013-08-14 |
2018-09-21 |
英商卡爾維斯塔製藥有限公司 |
雜環衍生物
|
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
|
CA2923503A1
(en)
*
|
2013-09-25 |
2015-04-02 |
Valorisation-Recherche |
Inhibitors of polynucleotide repeat-associated rna foci and uses thereof
|
|
CN106459013B
(zh)
|
2014-05-15 |
2019-10-25 |
阵列生物制药公司 |
作为trka激酶抑制剂的化合物及其用途
|
|
TN2016000542A1
(en)
|
2014-06-03 |
2018-04-04 |
Idorsia Pharmaceuticals Ltd |
Pyrazole compounds and their use as t-type calcium channel blockers
|
|
EP3193609A4
(de)
*
|
2014-09-10 |
2018-02-28 |
Epizyme, Inc. |
Substituierte pyrrolidin-carboxamid-verbindungen
|
|
ES2693052T3
(es)
|
2014-09-15 |
2018-12-07 |
Idorsia Pharmaceuticals Ltd |
Compuestos de triazol como bloqueantes de los canales de calcio de tipo T
|
|
CN104402819B
(zh)
*
|
2014-09-22 |
2016-08-24 |
安徽农业大学 |
一类双吡唑酰胺衍生物的制备及其在治理水稻黑条矮缩病中的应用
|
|
GB201421085D0
(en)
|
2014-11-27 |
2015-01-14 |
Kalvista Pharmaceuticals Ltd |
New enzyme inhibitors
|
|
GB201421083D0
(en)
|
2014-11-27 |
2015-01-14 |
Kalvista Pharmaceuticals Ltd |
Enzyme inhibitors
|
|
MY191736A
(en)
|
2014-12-23 |
2022-07-13 |
Axikin Pharmaceuticals Inc |
3,5-diaminopyrazole kinase inhibitors
|
|
AR103636A1
(es)
|
2015-02-05 |
2017-05-24 |
Teva Pharmaceuticals Int Gmbh |
Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
|
|
WO2016202758A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2016202756A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2016202935A1
(en)
|
2015-06-19 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Glucose transport inhibitors
|
|
DK3356345T3
(da)
*
|
2015-09-30 |
2024-02-12 |
Max Planck Gesellschaft |
Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
|
|
WO2017063966A1
(en)
|
2015-10-13 |
2017-04-20 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
|
|
CN108699015A
(zh)
|
2015-12-18 |
2018-10-23 |
默沙东公司 |
对电压门控性钠通道具有选择性活性的羟基烷基胺-和羟基环烷基胺-取代的二胺-芳基磺胺化合物
|
|
WO2017151786A1
(en)
|
2016-03-01 |
2017-09-08 |
University Of Maryland, Baltimore |
Wnt signaling pathway inhibitors for treatments of disease
|
|
ME03794B
(de)
|
2016-05-31 |
2021-04-20 |
Kalvista Pharmaceuticals Ltd |
Pyrazolderivate als plasma-kallikrein-inhibitoren
|
|
GB201609607D0
(en)
|
2016-06-01 |
2016-07-13 |
Kalvista Pharmaceuticals Ltd |
Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
|
|
GB201609603D0
(en)
|
2016-06-01 |
2016-07-13 |
Kalvista Pharmaceuticals Ltd |
Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
|
|
CN110291084A
(zh)
*
|
2016-12-15 |
2019-09-27 |
加利福尼亚大学董事会 |
用于治疗癌症的组合物和方法
|
|
HRP20220463T1
(hr)
|
2016-12-16 |
2022-05-27 |
Idorsia Pharmaceuticals Ltd |
Farmaceutska kombinacija koja sadrži blokator kalcijevih kanala t-tipa
|
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
|
WO2018127207A1
(zh)
*
|
2017-01-09 |
2018-07-12 |
南京明德新药研发股份有限公司 |
噻唑衍生物及其应用
|
|
WO2018141961A1
(en)
|
2017-02-06 |
2018-08-09 |
Idorsia Pharmaceuticals Ltd |
A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
|
|
US11491150B2
(en)
|
2017-05-22 |
2022-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
PL3716952T3
(pl)
|
2017-11-29 |
2022-05-02 |
Kalvista Pharmaceuticals Limited |
Postacie dawkowania zawierające inhibitor kalikreiny osoczowej
|
|
GB201719881D0
(en)
|
2017-11-29 |
2018-01-10 |
Kalvista Pharmaceuticals Ltd |
Solid forms of plasma kallikrein inhibitor and salts thereof
|
|
EA202190055A1
(ru)
|
2018-06-18 |
2021-04-23 |
Янссен Фармацевтика Нв |
Производные пиразола в качестве ингибиторов malt1
|
|
AU2019289223B2
(en)
|
2018-06-18 |
2023-09-21 |
Janssen Pharmaceutica Nv |
Pyrazole derivatives as MALT1 inhibitors
|
|
WO2020117626A1
(en)
|
2018-12-05 |
2020-06-11 |
Merck Sharp & Dohme Corp. |
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
US12404260B2
(en)
|
2019-04-11 |
2025-09-02 |
Janssen Pharmaceutica Nv |
Pyridine rings containing derivatives as MALT1 inhibitors
|
|
WO2021028645A1
(en)
|
2019-08-09 |
2021-02-18 |
Kalvista Pharmaceuticals Limited |
Plasma kallikrein inhibitors
|
|
CN114044754A
(zh)
*
|
2021-11-23 |
2022-02-15 |
贵州大学 |
一类5-三氟甲基-4-吡唑衍生物的制备方法及其在抑制肿瘤细胞上的应用
|
|
CN118695860A
(zh)
*
|
2022-02-23 |
2024-09-24 |
拜奥海芬治疗学有限公司 |
作为kv7通道激活剂的吡唑基化合物
|
|
CN119823046B
(zh)
*
|
2025-01-10 |
2025-10-03 |
河南农业大学 |
一种吡唑酰胺类化合物及其制备方法和应用
|